Product Code: ETC8534422 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Catheter-related Bloodstream Infections Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Catheter-related Bloodstream Infections Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Catheter-related Bloodstream Infections Market - Industry Life Cycle |
3.4 Netherlands Catheter-related Bloodstream Infections Market - Porter's Five Forces |
3.5 Netherlands Catheter-related Bloodstream Infections Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Netherlands Catheter-related Bloodstream Infections Market Revenues & Volume Share, By Source of Infection, 2021 & 2031F |
3.7 Netherlands Catheter-related Bloodstream Infections Market Revenues & Volume Share, By Hospital Pharmacies, 2021 & 2031F |
4 Netherlands Catheter-related Bloodstream Infections Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of catheter-related bloodstream infections in the Netherlands |
4.2.2 Growing awareness about the importance of infection prevention in healthcare settings |
4.2.3 Technological advancements in catheter materials and design |
4.3 Market Restraints |
4.3.1 High cost associated with implementing infection prevention measures |
4.3.2 Lack of standardization in infection control practices across healthcare facilities in the Netherlands |
5 Netherlands Catheter-related Bloodstream Infections Market Trends |
6 Netherlands Catheter-related Bloodstream Infections Market, By Types |
6.1 Netherlands Catheter-related Bloodstream Infections Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Catheter-related Bloodstream Infections Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 Netherlands Catheter-related Bloodstream Infections Market Revenues & Volume, By Anti-microbial Agents, 2021- 2031F |
6.1.4 Netherlands Catheter-related Bloodstream Infections Market Revenues & Volume, By Antibiotic Lock Therapy, 2021- 2031F |
6.2 Netherlands Catheter-related Bloodstream Infections Market, By Source of Infection |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Catheter-related Bloodstream Infections Market Revenues & Volume, By Coagulase-negative Staphylococcus, 2021- 2031F |
6.2.3 Netherlands Catheter-related Bloodstream Infections Market Revenues & Volume, By S. aureus, 2021- 2031F |
6.2.4 Netherlands Catheter-related Bloodstream Infections Market Revenues & Volume, By Enteric Gram-negative Bacilli, 2021- 2031F |
6.2.5 Netherlands Catheter-related Bloodstream Infections Market Revenues & Volume, By Yeasts, 2021- 2031F |
6.2.6 Netherlands Catheter-related Bloodstream Infections Market Revenues & Volume, By Enterococci & Streptococci, 2021- 2031F |
6.2.7 Netherlands Catheter-related Bloodstream Infections Market Revenues & Volume, By Pseudomonas, 2021- 2031F |
6.3 Netherlands Catheter-related Bloodstream Infections Market, By Hospital Pharmacies |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Catheter-related Bloodstream Infections Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.3 Netherlands Catheter-related Bloodstream Infections Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Netherlands Catheter-related Bloodstream Infections Market Import-Export Trade Statistics |
7.1 Netherlands Catheter-related Bloodstream Infections Market Export to Major Countries |
7.2 Netherlands Catheter-related Bloodstream Infections Market Imports from Major Countries |
8 Netherlands Catheter-related Bloodstream Infections Market Key Performance Indicators |
8.1 Rate of catheter-related bloodstream infections per 1,000 catheter days |
8.2 Compliance with infection prevention protocols in healthcare facilities |
8.3 Adoption rate of antimicrobial catheters |
8.4 Number of healthcare facilities implementing catheter care bundles |
8.5 Patient satisfaction with catheter-related care and infection prevention measures |
9 Netherlands Catheter-related Bloodstream Infections Market - Opportunity Assessment |
9.1 Netherlands Catheter-related Bloodstream Infections Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Netherlands Catheter-related Bloodstream Infections Market Opportunity Assessment, By Source of Infection, 2021 & 2031F |
9.3 Netherlands Catheter-related Bloodstream Infections Market Opportunity Assessment, By Hospital Pharmacies, 2021 & 2031F |
10 Netherlands Catheter-related Bloodstream Infections Market - Competitive Landscape |
10.1 Netherlands Catheter-related Bloodstream Infections Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Catheter-related Bloodstream Infections Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |